drugset / Trial / NCT07294846
Drug Interaction Study on Linaprazan Glurate Capsules
RandomizedParallel-groupOpen-labelBasic science
Summary
This study is a drug-drug interaction (DDI) investigation involving Linaprazan Glurate capsules and a combination of clarithromycin tablets, amoxicillin capsules, and bismuth potassium citrate capsules. The study plan is divided into two parts: one involving Hp-negative healthy subjects and the other involving Hp-positive subjects.
Timeline
- Start
- 2025-09-08
- Primary completion
- 2025-12-15
- Completion
- 2025-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bismuth Potassium Citrate | Unknown | — | — |
| Subject | Esomeprazole | Small molecule | 20 mg | — |
| Subject | Linaprazan glurate | Small molecule | 50 mg | — |
| Background | Amoxicillin | Other / unclassified | — | — |
| Background | Clarithromycin | Small molecule | — | — |
Indications
No indication recorded.